Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC -Amplified Group 3 Medulloblastoma by Droplet Digital PCR.
Natalia StepienDaniel SenfterJulia FurtnerChristine HaberlerChristian DorferThomas CzechDaniela Lötsch-GojoLisa MayrCora HedrichAlicia BaumgartnerMaria Aliotti-LippolisHannah SchnedJohannes HollerKatharina BrucknerIrene SlavcAmedeo A AziziAndreas PeyrlLeonhard MüllauerSibylle MadlenerJohannes GojoPublished in: Cancers (2023)
amplification in the CSF of MB patients. These results warrant implementation of liquid biopsy in future prospective clinical trials to validate the potential for improved diagnosis, disease staging and monitoring.